Position in MYGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$325,470
+$321,467 QoQ
Shares Held
57,000
+8655.8% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 195 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026UMB Bank, n.a. holds $48,554,459 across 22 Diagnostics & Research names. MYGN ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
33,872 | $16,982,065 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
24,639 | $12,970,954 | |
| 3 | DHR |
Danaher Corp /De/
|
43,995 | $8,380,166 | |
| 4 | DGX |
Quest Diagnostics Inc
|
33,268 | $7,051,152 | |
| 5 | A |
Agilent Technologies, Inc.
|
4,536 | $602,516 | |
| 6 | WAT |
Waters Corp /De/
|
1,180 | $442,546 | |
| 7 | ILMN |
Illumina, Inc.
|
2,022 | $355,528 | |
| 8 | MYGN |
Myriad Genetics Inc
This page
|
57,000 | $325,470 |
All Filings in MYGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $325,470 | 57,000 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $4,003 | 651 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,596 | 774 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $371 | 70 | Shares | Sole | 2025-07-11 | |
| 2024-12-31 | $3,482 | 254 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $5,669 | 207 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $2,494 | 102 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $767 | 36 | Shares | Sole | 2024-04-26 | |
| No filing history on record for this holder in this stock. | ||||||